(ITOS) – Analyst Ratings
-
Piper Sandler Reiterates Overweight Rating on iTeos Therapeutics (ITOS), 'this bodes well for ITOS’ initial data in this setting'
-
JPMorgan Assumes iTeos Therapeutics (ITOS) at Overweight
-
-
-
-
-
-
-
-
Back to ITOS Stock Lookup